UAE: 2,400 couples undergo premarital genetic screening; 92% found compatible
Around 2,400 couples have undergone premartial genetic screening so far with 92% found to be compatible, as part of the UAE's Genome Programme, it was announced on Friday.
Abu Dhabi Crown Prince Sheikh Khaled bin Mohammed bin Zayed Al Nahyan, who is also the Chairman of the Abu Dhabi Executive Council, chaired a meeting of the Emirates Genome Council, and the council approved programmes for newborn genetic screenings, expanded genetic screening for adults in the UAE Genome Programme, personalised fertility and cardiovascular genetic screening..
The Premarital Genetic Screening Programme was implemented from January 1, 2025 by the Ministry of Health and Prevention, in collaboration with the Department of Health – Abu Dhabi, Emirates Heath Services, Dubai Health Authority, and strategic partners.
To date, it has supported 2,428 couples, finding more than 92 per cent genetically compatible through comprehensive genetic screening of 570 genes linked to more than 840 genetic disorders. Couples who required additional support were provided personalised genetic counselling to assess and diagnose risk factors and offer potential solutions to support family planning decisions.
The programme aims to safeguard community members from hereditary diseases and empower couples to utilise genetic data to make informed decisions in family planning, preserving the health and wellbeing of community members and ensuring a healthier future for generations to come.
New population screening programmes
The Abu Dhabi Crown Prince endorsed new population screening programmes that expand the utilisation of genomic data and accelerate genome-driven personalised healthcare in the UAE. The programmes include newborn genetic screenings, enhanced screenings of adult participants in the Emirati Genome Programme, provision of personalised fertility programmes, and cardiovascular genetic screening.
The newborn genetic screening programme will assess genetic conditions with available treatments and early intervention options for infants, assessing 733 genes to test for more than 800 conditions.
Population disease screenings, for adults participating in the Emirati Genome Programme, aim to further identify actionable and relevant conditions for UAE nationals, by assessing 94 genes linked to more than 50 genetic conditions.
The personalised fertility programme assesses 186 genes linked to more than 130 genetic conditions, to provide personalised medicine recommendations and treatments for couples.
Cardiovascular screenings will provide genetic diagnosis and treatment, as well as early prevention, for cardiovascular related conditions through the assessment of more than 800 genes linked to more than 100 genetic conditions.
T2T Emirati Reference Genome study
Sheikh Khaled was briefed on the completion of the landmark Telomere-to-Telomere (T2T) Emirati Reference Genome study aimed at advancing precision medicine for communities in the UAE. The study, by the Department of Health – Abu Dhabi, in collaboration with Khalifa University and M42, bridges critical gaps in genomic data and provides a vital resource that enhances the ability to compare with other reference genomes, supporting the advancement of disease research, pharmacogenomics and the development of Emirati-specific targeted therapies.
Emirati Genome Programme progress
The Abu Dhabi Crown Prince was also updated on the progress of the Emirati Genome Programme, which has collected more than 700,000 genetic samples from citizens across the nation, marking significant progress towards the overall target of 1 million.
In addition, the Emirati Genome Programme has completed the collection of 100,000 samples from participants from different nationalities for a new initiative that leverages the UAE's advanced genomic capabilities. The project, in collaboration with M42, helps reduce gaps in genomic data globally by providing insights into genetic mutations affecting over 2.5 billion people across different ethnicities, with the aim to drive further collaboration on precision medicine research and solutions.
The Emirati Genome Programme is a key project under the National Genome Strategy and will support the transformation of healthcare services in the UAE by providing high-quality genetic data that enables researchers, physicians and scientists to identify the causes of genetic diseases, understand the type of genetic mutations, anticipate susceptibility to some diseases, and develop effective personalised healthcare plans.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
2 days ago
- Al Etihad
Department of Health - Abu Dhabi highlights sickle cell awareness efforts
19 June 2025 14:30 ABU DHABI (WAM)Executive Director of the Health Life Sciences Sector at the Department of Health – Abu Dhabi (DoH), Dr. Asma Al Mannaei, affirmed that World Sickle Cell Day, marked annually on 19th June, is a vital occasion to raise awareness about the disease, support patients and their families, and shed light on efforts aimed at reducing its health and social Al Mannaei told WAM that Sickle cell disease remains a significant public health concern globally, affecting the quality of life for patients and placing long-term pressure on families. "At the Department of Health – Abu Dhabi, we are committed to reshaping that reality through innovation, early detection and personalised care. Our mission is to foster a healthy population, deliver best-in-class care, and drive continuous resilience and innovation."Dr. Al Mannaei added, "Supported by powerful Artificial Intelligence tools, driven by data and genomic sciences, we are building a system that predicts, prevents and acts.""Our efforts begin with prevention. Through the Premarital Genetic Screening Programme, we empower couples to make informed decisions that help reduce the prevalence of genetic conditions such as sickle cell in future generations."She continued, 'We then move to prediction, where we are shifting from a reactive approach to proactive and personalised care approach for sickle cell, by utilising platforms such as the Emirati Genome Programme. By integrating sickle cell disease in the newly launched Newborn Genetic Screening Programme, we can ensure early detection, timely intervention and healthier outcomes for families across the Emirate.'Dr. Al Mannaei also praised the introduction of innovative treatments. In collaboration with the Abu Dhabi Stem Cells Centre and global partner Vertex Pharmaceuticals, the Department has introduced CASGEVY, a CRISPR/Cas9-based gene-editing therapy for patients with sickle cell disease and transfusion-dependent beta-thalassaemia."This marks the first time this cutting-edge treatment is available in the UAE," she added that, beyond treatment, investment in scientific research remains a top priority. In partnership with the Authority of Social Contribution – Ma'an, and through the Research and Innovation Fund, the Department is supporting research that addresses key healthcare priorities. One of the grant awardees received funding for research focused on anaemia and sickle cell disease, examining their impact on healthspan.
Hi Dubai
5 days ago
- Hi Dubai
MoHAP Launches Digital System to Streamline Healthcare Fine Collection and Boost Efficiency
The Ministry of Health and Prevention (MoHAP) has rolled out a new digital system to automate the collection of healthcare fines, aiming to boost financial compliance, reduce bureaucracy, and support the UAE's digital transformation goals. Part of the Zero Government Bureaucracy Programme, the system offers a unified platform that simplifies fine payments, improves task management, and enhances technical support. By fully automating financial procedures, the initiative enables healthcare providers to focus more on patient care while reducing administrative overhead. Officials say the platform improves data accuracy, accelerates service delivery, and aligns with federal debt collection laws. It also strengthens regulatory compliance across the private healthcare sector, paving the way for a more flexible and competitive environment. Abdullah Ahli, Acting Assistant Under-Secretary for the Support Services Sector, called the system a 'major advancement in violation management,' noting that it provides a faster and more transparent process for resolving fines. He highlighted the Ministry's broader strategy to build strong public-private partnerships and improve healthcare competitiveness. Amna Al Mandoos, Head of the Revenue Section at MoHAP, said the system supports national goals under We the UAE 2031 by offering multiple digital payment options, reducing errors, and enhancing customer satisfaction. She emphasized its role in easing compliance and boosting operational efficiency across healthcare facilities. The initiative marks a key step in MoHAP's wider adoption of emerging technologies to modernize public services and deliver smarter, more sustainable healthcare solutions. News Source: Emirates News Agency
Al Etihad
6 days ago
- Al Etihad
Abu Dhabi reinforces global leadership in healthcare innovation with high-level US visit
15 June 2025 17:41 ABU DHABI (WAM) A high-level delegation led by the Department of Health – Abu Dhabi (DoH), is set to embark on a strategic mission to the United States from June 14-21, visit reaffirms Abu Dhabi's global leadership in healthcare innovation and reflects its broader vision for healthcare transformation—driven by innovation, investment, and a deep commitment to global delegation will visit key US cities including Boston, Washington D.C., and Philadelphia, in parallel with Abu Dhabi's participation at BIO International Convention 2025, one of the world's foremost biotechnology visit will spotlight the Emirate's achievements in AI, digital health, genomics, and clinical research and showcase Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Life Science Cluster, while promoting long-term strategic partnerships with government entities, research institutions, and global Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated, 'This mission reflects our commitment to shaping the future of health through collaboration, innovation, and shared purpose. Our vision is to build a health system that predicts, prevents, acts to restore, and acts to cure, therefore ensuring better outcomes for our communities and beyond. "This can only be achieved through meaningful partnerships and a shared ambition to improve lives. We are proud to join our partners in the United States to explore new opportunities that advance healthcare, both in the UAE and globally.'The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the US, aimed at knowledge exchange, investment opportunities, and the signing of new agreements that accelerate the adoption of advanced health Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Dhabi continues to lead the region in genomics through the Emirati Genome Programme, which has successfully sequenced over 800,000 samples, creating one of the most advanced national genomic databases. The Emirate is also home to more than 90 licenced research centers and 30+ ongoing clinical trials in areas such as oncology, rare diseases, and chronic conditions. Advanced data platforms such as Malaffi, which securely store over 5 million patient records—enable AI-powered insights and real-world evidence, while national initiatives like the Golden Visa programme are cultivating a global workforce and have granted over 2,000 long-term visas for researchers and healthcare professionals from around the world.
